|
|
||||||||
1From the Department of Experimental Therapeutics, Translational Research Center, Kyoto University Hospital, Kyoto, Japan; the 2Departments of Ophthalmology and Visual Sciences and 5Anatomy and Neurobiology, Graduate School of Medicine, and the 4Departments of Medical Embryology and Neurobiology and 6Development and Differentiation and the 7Stem Cell Research Center, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan; and the 3Organogenesis and Neurogenesis Group, Center for Developmental Biology, RIKEN, Kobe, Japan.
| Abstract |
|---|
|
|
|---|
METHODS. Cynomolgus monkey ES cells were induced to differentiate into pigment epithelial cells by coculturing them with PA6 stromal cells in a differentiating medium. The expanded, single-layer ESPEs were examined by light and electron microscopy. The expression of standard RPE markers by the ESPEs was determined by RT-PCR, Western blot, and immunocytochemical analyses. The ESPEs were transplanted into the subretinal space of 4-week-old Royal College of Surgeons (RCS) rats, and the eyes were analyzed immunohistochemically at 8 weeks after grafting. The effect of the ESPE graft on the visual function of RCS rats was estimated by optokinetic reflex.
RESULTS. The expanded ESPEs were hexagonal and contained significant amounts of pigment. The ESPEs expressed typical RPE markers: ZO-1, RPE65, CRALBP, and Mertk. They had extensive microvilli and were able to phagocytose latex beads. When transplanted into the subretinal space of RCS rats, the grafted ESPEs enhanced the survival of the host photoreceptors. The effects of the transplanted ESPEs were confirmed by histologic analyses and behavioral tests.
CONCLUSIONS. The ESPEs had morphologic and physiological properties of normal RPE cells, and these findings suggest that these cells may provide an unlimited source of primate cells to be used for the study of pathogenesis, drug development, and cell-replacement therapy in eyes with retinal degenerative diseases due to primary RPE dysfunction.
Embryonic stem (ES) cells retain significant developmental potential and replicative capability and are expected to alleviate the problem of the shortage of donor cells for cell-replacement therapy. The isolation and use of human ES cells3 4 has drawn much attention because of their potential clinical applications in patients with degenerative diseases. However, the use of human ES cells for cell-replacement therapy is questionable at the moment because their differentiation is poorly controlled. Compared with the extensive potential demonstrated by mouse ES cells,5 6 there is no reported case showing that primate ES cells can be successfully applied to animal disease models. As the characteristics of rodent ES cells differ considerably from those of primate ES cells,3 4 7 8 it is necessary to develop methods to induce primate ES cells to differentiate into a homogeneous population of functional cells that can be used for cell-replacement therapy.
The purpose of the study was to determine whether primate embryonic stem-cellderived pigment epithelial cells (ESPEs) develop the well-known characteristics of RPE cells and have functional properties that would be of value in treating diseases when transplanted in an animal model of RPE dysfunction.
| Materials and Methods |
|---|
|
|
|---|
RT-PCR Analysis
Total RNA was isolated (RNeasy Protect Mini Kit with RNase-Free DNase Set; Qiagen, Chatsworth, CA) and first-strand cDNA was synthesized (First-Strand cDNA Synthesis Kit; Amersham Biosciences, Piscataway, NJ) according to the manufacturers protocol. The PCR reaction was performed with the following primers: for RPE65, 5'-TGGAGTCTTTGGGGAGCCAA-3' and 5'-CTCACCACCACACTCAGAAC-3'; for cellular retinaldehyde-binding protein (CRALBP), 5'-GTGGACATGCTCCAGGATTC-3' and 5'-CCAAAGAGCTGCTCAGCAAC-3'; for Mertk, 5'-GGGAGATCGAGGAGTTTCTC-3' and 5'-CGGCCTTGGCGGTAATAATC-3'; for ß-actin, 5'-CTTCAACACCCCAGCCATGT-3' and 5'-ACTCCTGCTTGCTGATCCAC-3'.
Western Blot Analysis
Western Blot Analysis was performed as described.11 Rabbit polyclonal anti-CRALBP antibody (1:40,000, kindly provided by John C. Saari, University of Washington, Seattle, WA) was used as the primary antibody.
Animals
All animal experiments were conducted in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and were approved by the Animal Research Committee, Graduate School of Medicine, Kyoto University. Pink-eyed dystrophic Royal College of Surgeons (RCS) rats and congenic nondystrophic rats were obtained from CLEA Japan (Tokyo, Japan).
Transplantation Procedures
Patches of ESPEs were collected by carefully cutting the peripheral margins with disposable scalpels. The patches of ESPEs were gently dissociated with the Papain Dissociation System (Worthington Biochemical, Lakewood, NJ) according to the manufacturers protocol. Dissociated ESPEs were incubated in the CM-DiI (chloromethylbenzamido derivatives of 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate; Molecular Probes, Eugene, OR) solution at a concentration of 5 µg/mL for 20 minutes at 37°C. Labeled ESPEs were then washed three times with PBS. The viability of the ESPEs after these procedures was more than 95%, as assessed by trypan blue exclusion. The cells were centrifuged and then concentrated to approximately 10,000 cells/µL in PBS.
The surgical and grafting procedures have been described in detail.13 14 ESPE cells, suspended in 3 µL of PBS, were injected transsclerally into the dorsotemporal subretinal space of anesthetized 4-week-old RCS rats. All transplantations were made into the left eye. Sham-treated RCS rats received the same amount of carrier medium. A total of 41 RCS rats received ESPE grafts, and 21 had sham injection. Transplantation into the subretinal space was confirmed by direct observation of the rat fundus with a contact lens (Kyocon, Kyoto, Japan), and those that had successful transplantation were selected for histologic analyses and behavioral tests. All the animals were maintained on oral cyclosporine (200 mg/L in drinking water; Calbiochem, Darmstadt, Germany) from 2 days before transplantation until they were killed. The blood cyclosporine levels in these animals were measured by SRL Inc. (Tokyo, Japan).
Immunostaining
Standard immunocytochemical techniques were used for the in vitro studies.15 The working dilution of the rabbit polyclonal anti-ZO-1 antibody (Zymed, South San Francisco, CA) was 1:50. Eyes (n = 4 for each group) were harvested 8 weeks after transplantation at age 12 weeks and fixed in 4% paraformaldehyde. Sixteen-micrometer sections were cut with a cryostat, stained, and processed for light or transmission electron microscopy as described.16
The working dilution of the mouse monoclonal anti-rhodopsin antibody (Sigma-Aldrich, St. Louis, MO) was 1:2000. The nuclei were stained with Cytox blue (1:500 in distilled water; Molecular Probes) and the specimens were observed and photographed with a laser-scanning confocal microscopy (TCS SP2; Leica, Heidelberg, Germany). The maximum thickness of the outer nuclear layer (ONL) in the dorsotemporal and ventronasal retina (n = 4 animals for each group) was measured, and the differences were analyzed with the Mann-Whitney test.
Transmission Electron Microscopy and Phagocytosis of Latex Beads
ESPEs grown on 60 mm synthetic-matrixcoated dishes (Matrigel; BD Biosciences) were processed for transmission electron microscopy as described.16 To examine phagocytotic ability,17 the ESPEs were incubated with 1-µm latex beads (Sigma-Aldrich) at a concentration of 1.0 x 109 beads/mL for 6 hours at 37°C. The ESPEs were washed five times with PBS and then processed for transmission electron microscopy.
Behavioral Assessment
For behavioral assessment, a head-tracking apparatus (Hayashi Seisakusho, Kyoto, Japan) that consisted of a circular drum rotating around a stationary holding chamber containing the animal was used.13 The speed of rotation of the drum with vertical black-and-white stripes (10° each) was set at 2, 4, and 8 rpm. Animals (n = 4 animals for each group) were tested at 8 weeks after transplantation at 12 weeks of age before they were killed. A video camera mounted above the apparatus recorded the head movements. The total amount of head-tracking time was determined at speeds of 2, 4, and 8 rpm during a 4-minute test period for each speed. A single operator, masked to the type of animals being tested, conducted all assessments, and the code was broken after the completion of all data acquisition. Behavioral data were analyzed with the Mann-Whitney test.
| Results |
|---|
|
|
|---|
|
|
We next examined the expression of specific molecules closely related to the cellular function of normal RPE cells (i.e., RPE65 and CRALBP, both of which are involved in regeneration of visual pigment and are strongly expressed in normal RPE cells).18 19 Mertk, a tyrosine kinase receptor gene, is essential for the phagocytosis of photoreceptor outer segments by RPE cells20 21 and is expressed not only in RPE but also in undifferentiated ES cells and in various hematopoietic cell lines.22 RPE65, CRALBP, and Mertk are essential for normal visual functions, because a mutation in any of these three genes in humans causes visual disturbances.23 24 25 26 RT-PCR detected the expression of the mRNA of RPE65, CRALBP, and Mertk in the ESPEs. In addition, Western blot analysis confirmed the expression of the CRALBP protein in the ESPEs, which yielded a single band of the appropriate size (Fig. 1G) .
To function and be viable, photoreceptor cells require a continuous phagocytosis of their shed outer segments by adjacent RPE cells.1 There are two separate mechanisms for phagocytosis in RPE cells in vitro: a nonspecific process (as seen with the uptake of latex beads) and a specific uptake of shed outer segment fragments involving a receptor-mediated event. To examine whether ESPEs had phagocytic capability, they were incubated with 1-µm fluorescent latex beads.17 When observed by a fluorescence light microscope, the abundant melanin granules in the ESPE cytoplasm obscured the bead-specific fluorescence. However, transmission electron microscopy clearly showed that the ESPEs had ingested the latex beads (Fig. 2B) .
Transplantation into a Rat Model with RPE Dysfunction
RCS rats show a progressive photoreceptor loss, which is mostly marked during the first 3 months after birth.27 Retinal degeneration in the RCS rat is primarily due to the failure of the RPE cells to phagocytose shed outer segments,28 which is the result of a mutation of the receptor tyrosine kinase gene (Mertk).29 Subretinal transplantation of fetal RPE cells into the dystrophic RCS rat at an early age resulted in structural and functional preservation of photoreceptors.30 31
We used this animal model to explore the ability of ESPEs to rescue the function in host animals. The host animals were given cyclosporine to prevent xenograft rejection of the monkey ESPEs. At the termination of the experiments, the mean blood cyclosporine level in these animals was 244 ± 73.0 ng/mL, and there was no histologic evidence of any inflammatory immune reaction at the site of cell injection.
When the animals were 12 weeks old (8 weeks after transplantation), the heavy pigmentation of the ESPEs made it easy to identify them in the pink-eyed host RPE cells phagocytosing pigment debris of donor cells (Fig. 3A) . Prelabeling the ESPEs with CM-DiI also confirmed that these heavily pigmented cells in the host subretinal space were derived from the donor cells (Figs. 3A 3B 3C) .
|
The maximum ONL thickness was significantly greater in the ESPE-grafted RCS rat group than in the sham-treated RCS rat group or in the untreated RCS rat group (Fig. 3G ; Mann-Whitney analysis, P < 0.05). In every ESPE-grafted eye, the maximum ONL thickness of the dorsotemporal retina (ESPE-grafted quadrant) was greater than that of the ventronasal retina of the same eye (Fig. 3G) . In contrast, in the nonsurgical eyes, there was no significant difference in the maximum ONL thickness between the dorsotemporal and the ventronasal retina (Fig. 3G) .
Immunohistochemical analysis showed that the preserved photoreceptors expressed rhodopsin, visual pigment used by the rod photoreceptor cells to perform phototransduction (Fig. 3F) . Electron microscopy of the grafted ESPEs revealed the presence of lamellar structures within the pigmented ESPEs (Fig. 4) . These results indicate that the ESPEs developed a capability to promote the survival of photoreceptor cells in an animal model of RPE dysfunction.
|
|
| Discussion |
|---|
|
|
|---|
The grafted ESPEs probably preserved the photoreceptors in the RCS rat retina, either by phagocytosing the hosts outer segments1 or by secreting soluble growth factors.32 Although ESPEs are able to phagocytose latex beads (Fig. 2B) , we have not measured their ability to phagocytose photoreceptor outer segments in vitro. However, phagosome-like bodies were seen in the grafted ESPEs by electron microscopy (Fig. 4) , suggesting that grafted ESPEs had the ability to ingest host shed outer segments. The results of transplantation may have been even better if we could have transplanted an organized patch of ESPEs instead of dissociated cells, because, in such a patch, cellular polarity and tight junctions seem more likely to develop.
An earlier study reported the retinal transplantation of neural precursors that had been differentiated from mouse ES cells.33 The transplanted cells probably slowed the photoreceptor degeneration in RCS rats by secreting some growth factors, because grafted neural precursors can neither phagocytose host shed outer segments nor differentiate into photoreceptor cells. In contrast, our results showed that ESPEs from primate ES cells can differentiate and develop characteristic properties of RPE cells, which would be necessary for the treatment of primary RPE dysfunction and for the long-term preservation of visual function after retinal transplantation.
If undifferentiated cells are contaminated, transplantation of ES cell-derived cells might involve the risk of tumor formation in the host animal. However, no tumors were observed in the animals that received ESPE grafts in our study. One reason for this may be that we selectively expanded the ESPEs as patches of cells on the matrix-coated dishes and generated relatively pure populations of donor pigment epithelial cells. These procedures may have kept unwanted cell populations from contaminating the donor cells.
Because both undifferentiated primate ES cells and ESPEs can be expanded in vitro, it is possible to generate an unlimited number of ESPEs for retinal transplantation. Considering the close phylogenetic relationship between humans and cynomolgus monkeys, we can also expect that the methods of differentiation used to generate ESPEs can be applied to human ES cells. Human retinal diseases for which ESPE transplantation may be used include age-related macular degeneration and hereditary retinal degeneration due to primary RPE dysfunction, such as some forms of retinitis pigmentosa.
One substantial problem to be solved is the control of immunologic rejection after the transplantation of allograft tissue. It is therefore important to determine in future studies how much immunosuppression is necessary after ESPE transplantation into the subretinal space, which is sometimes regarded as an immunologically privileged site for retinal allografts.34 The transplantation of monkey ESPEs into the monkey subretinal space would provide a more accurate model for the allograft transplantation of human ESPEs into other humans.
Our results indicate that the expected morphologic, biochemical, and functional characteristics of RPE cells developed in the expanded ESPEs in vitro. After transplantation of the ESPEs into the subretinal space of an animal model of RPE dysfunction, the grafted ESPEs enhanced the survival of host photoreceptors. These effects were demonstrated both by histologic analyses and behavioral tests. To the best of our knowledge, this is the first study to show detailed functioning of specific cells differentiated from primate ES cells both in vitro and in vivo. In addition, this is also the first study to demonstrate the successful therapeutic application of primate ES cells in an animal disease model. As human ES cells significantly differ from mouse ES cells but closely resemble nonhuman primate ES cells, the latter would be more suitable for preclinical research aimed at cell-replacement therapies. Before human ESPEs are used in clinical trials, however, long-term studies of retinal transplantation in nonhuman primate hosts are necessary to confirm the cells safety and efficacy.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication September 20, 2003; revised November 8 and 28, 2003; accepted December 3, 2003.
Disclosure: M. Haruta, None; Y. Sasai, None; H. Kawasaki, None; K. Amemiya, None; S. Ooto, None; M. Kitada, None; H. Suemori, None; N. Nakatsuji, None; C. Ide, None; Y. Honda, None; M. Takahashi, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Masayo Takahashi, Department of Experimental Therapeutics, Translational Research Center, Kyoto University Hospital, Kyoto 606-8507, Japan; masataka{at}kuhp.kyoto-u.ac.jp.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Wang, S. Girman, B. Lu, N. Bischoff, T. Holmes, R. Shearer, L. S. Wright, C. N. Svendsen, D. M. Gamm, and R. D. Lund Long-term Vision Rescue by Human Neural Progenitors in a Rat Model of Photoreceptor Degeneration Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3201 - 3206. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ueno, M. Matsumura, K. Watanabe, T. Nakamura, F. Osakada, M. Takahashi, H. Kawasaki, S. Kinoshita, and Y. Sasai Neural conversion of ES cells by an inductive activity on human amniotic membrane matrix PNAS, June 20, 2006; 103(25): 9554 - 9559. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Banin, A. Obolensky, M. Idelson, I. Hemo, E. Reinhardtz, E. Pikarsky, T. Ben-Hur, and B. Reubinoff Retinal Incorporation and Differentiation of Neural Precursors Derived from Human Embryonic Stem Cells Stem Cells, February 1, 2006; 24(2): 246 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sasaki, K. Hanazawa, R. Kurita, A. Akatsuka, T. Yoshizaki, H. Ishii, Y. Tanioka, Y. Ohnishi, H. Suemizu, A. Sugawara, et al. Establishment of Novel Embryonic Stem Cell Lines Derived from the Common Marmoset (Callithrix jacchus) Stem Cells, September 1, 2005; 23(9): 1304 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ikeda, F. Osakada, K. Watanabe, K. Mizuseki, T. Haraguchi, H. Miyoshi, D. Kamiya, Y. Honda, N. Sasai, N. Yoshimura, et al. Generation of Rx+/Pax6+ neural retinal precursors from embryonic stem cells PNAS, August 9, 2005; 102(32): 11331 - 11336. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |